ANIK
Anika Therapeutics Inc
Price:  
24.83 
USD
Volume:  
220,823.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika EV/EBITDA

-88.4%
Upside

As of 2024-02-23, the EV/EBITDA ratio of Anika Therapeutics Inc (ANIK) is -135.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Anika's latest enterprise value is 292.81 mil USD. Anika's TTM EBITDA according to its financial statements is -2.16 mil USD. Dividing these 2 quantities gives us the above Anika EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.3x - 11.9x 11.7x
Forward P/E multiples 13.0x - 17.1x 14.8x
Fair Price 2.91 - 3.08 2.87
Upside -88.3% - -87.6% -88.4%
24.83 USD
Stock Price
2.87 USD
Fair Price

Anika EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-22 -14.79
2024-02-21 -14.66
2024-02-20 -14.44
2024-02-16 -14.42
2024-02-15 -14.65
2024-02-14 -14.05
2024-02-13 -13.88
2024-02-12 -14.30
2024-02-09 -14.31
2024-02-08 -14.09
2024-02-07 -13.94
2024-02-06 -14.26
2024-02-05 -13.95
2024-02-02 -13.76
2024-02-01 -13.94
2024-01-31 -14.01
2024-01-30 -14.60
2024-01-29 -14.94
2024-01-26 -14.53
2024-01-25 -14.40
2024-01-24 -13.81
2024-01-23 -13.64
2024-01-22 -13.36
2024-01-19 -13.25
2024-01-18 -13.37
2024-01-17 -13.37
2024-01-16 -13.07
2024-01-12 -13.33
2024-01-11 -13.64
2024-01-10 -13.79
2024-01-09 -13.37
2024-01-08 -13.47
2024-01-05 -13.15
2024-01-04 -13.22
2024-01-03 -13.48
2024-01-02 -13.50
2023-12-29 -13.50
2023-12-28 -13.48
2023-12-27 -13.51
2023-12-26 -13.58
2023-12-22 -13.88
2023-12-21 -13.49
2023-12-20 -13.26
2023-12-19 -13.38
2023-12-18 -13.34
2023-12-15 -13.29
2023-12-14 -13.44
2023-12-13 -13.41
2023-12-12 -12.90
2023-12-11 -12.94